Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

VisCardia

Request full access

VisCardia Inc is privately held medical device company in Portland Oregon commercializing a proprietary implantable medical therapy

Beaverton, United StatesFounded 2015Health Tech & Medtech

About VisCardia

VisCardia Inc., based in Portland, Oregon, is a privately held medical device developer specializing in innovative therapies for heart failure. The company has developed a novel implantable device therapy known as Synchronized Diaphragmatic Stimulation (SDS) aimed at treating patients with reduced ejection fraction and preserved ventricular synchrony. This therapy offers a minimally invasive alternative to traditional, more complicated surgical procedures, addressing a significant gap in clinical care for heart failure patients who do not respond adequately to drug treatments.

VisCardia's primary market includes cardiology clinics and hospitals, particularly those treating elderly patients who are more prone to heart failure. The business model revolves around the development, clinical testing, and eventual commercialization of its SDS therapy. Revenue generation is expected through the sale of the implantable devices and associated medical services.

The company has completed initial clinical studies in Europe and is actively presenting its findings at major cardiology scientific meetings such as ESC, HFSA, ACC, and AHA. These efforts aim to validate the efficacy and safety of the SDS therapy, paving the way for broader market adoption.

Source: Dealroom company data

At a glance

Status
Operational
Employees
11
Open positions
2
Dealroom signal
52.3/100
Industry
Health
Sub-industry
Medical Devices
Sector
medical implants, Chronic Disease, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Feb 2017 $13M $50M Kinetic Capital —
SEED✓Equity / VC Jun 2016 $400K $1.6M Undisclosed —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

VisCardia website traffic

Latest recorded traffic for VisCardia is 1K monthly website visits, up 455.6% over the last three months. VisCardia's team grew 37.5% over the past year.

Latest monthly visits1K 3-month web change+455.6% 1-year team growth+37.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

VisCardia in the Beaverton ecosystem

Live from Dealroom

The VisCardia office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Kinetic Capital
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See VisCardia’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.